Documents in a lawsuit filed against Johnson & Johnson by two former salesmen show how the pharmaceutical giant sought to boost sales of its blockbuster anti-anemia drug Procrit by offering contracts that fattened doctors' profits and urging its salespeople to push higher-than-approved doses.
The documents provide a rare window into the complex case that is adding to the legal problems piling up on the health-care giant. J&J is answering questions in multiple federal and state investigations and in whistleblower suits alleging illegal marketing or pricing of its products.
More at the WSJ Health Blog
Ed at Pharmalot also has great coverage of the story.
No comments:
Post a Comment